Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/30/1995 | EP0668864A1 Substituted biphenylmethylimidazopyridines |
08/30/1995 | EP0668862A1 Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates |
08/30/1995 | EP0668860A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
08/30/1995 | EP0668854A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
08/30/1995 | EP0668853A1 Succinic acid derivatives for use as skin conditioners. |
08/30/1995 | EP0668785A1 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
08/30/1995 | EP0668782A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
08/30/1995 | EP0668781A1 Lymphokine gene therapy of cancer |
08/30/1995 | EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
08/30/1995 | EP0668766A1 Small molecule inhibition of rna/ligand binding |
08/30/1995 | EP0668764A1 Methods for identifying and using low/non-addictive opioid analgesics |
08/30/1995 | EP0668763A1 Use of phenserine to treat cognitive disorders |
08/30/1995 | EP0668762A1 Butenyl-substituted taxanes and composition |
08/30/1995 | EP0668761A1 Pharmaceutical formulations of ibuprofen |
08/30/1995 | EP0668760A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
08/30/1995 | EP0668759A1 Transdermal delivery of ketorolac |
08/30/1995 | EP0668758A1 Drug delivery device |
08/30/1995 | EP0631500A4 1-g(a)-HYDROXY-24--i(EPI)-VITAMIN D 4?. |
08/30/1995 | EP0630216A4 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like. |
08/30/1995 | EP0561866B1 Lyophilized amino acid compositions containing glutamine |
08/30/1995 | EP0556256B1 Aerosol medicaments |
08/30/1995 | EP0556239B1 Aerosol containing medicaments |
08/30/1995 | EP0540686B1 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
08/30/1995 | EP0465663B1 Dermatologic preparation |
08/30/1995 | CN1107639A Pyridothiazineacetic acid compound, process for producing the same, and use thereof |
08/30/1995 | CN1107476A Heterocyclic compounds, their production and use |
08/30/1995 | CN1107475A Pyrrolidine derivatives inhibitors of lfukotriene biosynthesis |
08/30/1995 | CN1107473A 4-Arylamino-benzopyran and related compounds |
08/30/1995 | CN1107469A Cyclic amine derivatives |
08/30/1995 | CN1107467A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
08/30/1995 | CN1107463A Asymmetrically substituted diaminodicarboxylic acid derivatives and a process for their preparation |
08/30/1995 | CN1107367A Stabilized pharmaceutical compositions and stabilizing solvent |
08/30/1995 | CN1107365A A novel physiologically active substance |
08/30/1995 | CN1107364A Pharmaceutical combination |
08/30/1995 | CN1107363A Alcohol or aldehyde derivatives and their use |
08/30/1995 | CN1107359A Galenic composition |
08/30/1995 | CN1107355A Pharmaceutical preparations having antithrombotic activity and process for preparing same |
08/30/1995 | CN1107334A Oral medicine for reducing cholesterol |
08/30/1995 | CN1107333A Long-acting prodrug of nabufrine analgesic and preparing process thereof |
08/30/1995 | CN1107332A Methods of inhibiting CNS problems in postmenopausal women |
08/30/1995 | CN1107331A Sustained release pharmaceutical composition |
08/30/1995 | CN1107329A Spray medicine for gullet |
08/30/1995 | CN1029617C Process and composition for purification of amphotericin B |
08/30/1995 | CN1029615C Novel 2,6-Di-alkyl-4-silyl-phenols as antiatherosclerotic agents |
08/30/1995 | CN1029614C Bis-|4-(2,6-di-alkyl) phenol¨ silane derivatives as antiathe-rosclerotic agents |
08/30/1995 | CN1029613C Aryl oxime carbamates and aryl oxime carbonates as bronchodilators and auti-inflamatory agents |
08/29/1995 | US5446189 Diester intermediates for diacid enzyme inhibitor |
08/29/1995 | US5446187 Antitumor agent |
08/29/1995 | US5446177 No increase in intraocular pressure during chronic use |
08/29/1995 | US5446161 Amino acid derivatives |
08/29/1995 | US5446159 Process for preparing imidazopyridine derivatives |
08/29/1995 | US5446157 Boron difluoride compounds useful in photodynamic therapy and production of laser light |
08/29/1995 | US5446153 Intermediates for imidazo[4,5-c]pyridin-4-amines |
08/29/1995 | US5446152 Antiemetic agent |
08/29/1995 | US5446139 Purine analog nucleoside and nucleotide compounds |
08/29/1995 | US5446121 Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
08/29/1995 | US5446071 Administering anticholesterol agents |
08/29/1995 | US5446070 Flexible, finite, bioadhesive, therapeutical agent in solid form |
08/29/1995 | US5446066 Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation |
08/29/1995 | US5446063 Anesthetic compositions |
08/29/1995 | US5446061 Methods for lowering serum cholesterol |
08/29/1995 | US5446060 Aminoalkyl thienyl ketone derivatives and their use as peripheral vasodilators |
08/29/1995 | US5446059 Treating or preventing inflammatory or immunoallergic conditions |
08/29/1995 | US5446058 (Fused) benz(thio)amides |
08/29/1995 | US5446054 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
08/29/1995 | US5446053 Administering raloxifene or derivative |
08/29/1995 | US5446052 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
08/29/1995 | US5446049 Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists |
08/29/1995 | US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias |
08/29/1995 | US5446041 Applying to treat glaucoma with reduced side effects |
08/29/1995 | US5446039 Treating nervous system and brain disorder, acting as excitatory amino acid antagonist |
08/29/1995 | US5446038 Microbiocides |
08/29/1995 | US5446036 13-alkyl-11beta-phenylgonanes |
08/29/1995 | US5446035 Stabilize blood calcium and phosphate levels, induce cell differentiation |
08/29/1995 | US5446034 Vitamin D analogues |
08/29/1995 | US5446033 Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers |
08/29/1995 | US5446030 With an anionic oligosaccharide |
08/29/1995 | US5446028 Peroxide and an antibiotic selected from lincomycin family of antibiotics comprises clindamycin or salt or ester |
08/29/1995 | US5445941 Method for screening anti-osteoporosis agents |
08/29/1995 | US5445830 Hypotensive agent mixed with ph-dependent copolymers of acrylic acid, methacrylic acid, their esters and/or their salts in organic solvents, then desolventized |
08/29/1995 | US5445827 Granules consisting of ibuprofen sodium salt, sodium hydrogen carbonate, polyvinylpyrrolidone, sodium carbonate, citric acid |
08/29/1995 | US5445826 Prolonged-release unit dosage formulation; includes a mineral salt which releases a physiologically-acceptable gas upon ingestion |
08/29/1995 | US5445823 Benzoyl peroxide and a compound for reducing skin irritation associated with it |
08/29/1995 | US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use |
08/29/1995 | US5445816 Depigmenting cosmetic and/or dermatological composition containing a di- or tri-caffeoylquninic acid, or a mixture thereof |
08/29/1995 | US5445812 Angiographic adjuvant |
08/29/1995 | US5445604 Wound dressing with conformable elastomeric wound contact layer |
08/29/1995 | CA2093826C Process for preparing optically active cyanohydrins with enzymes |
08/29/1995 | CA2054870C Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
08/29/1995 | CA2053000C Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula |
08/29/1995 | CA2002558C Copper complexes of alpha-amino acids that contain terminal amino acid groups, and their use as nutritional supplements |
08/29/1995 | CA1336835C Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
08/29/1995 | CA1336833C Piperidine derivatives |
08/29/1995 | CA1336825C Use and agent for reducing the side effects of tnf |
08/29/1995 | CA1336824C Method of safely providing anesthesia or conscious sedation |
08/29/1995 | CA1336823C Method of treating neurological disorders |
08/29/1995 | CA1336822C Intramuscular injection forms of gyrase inhibitors |
08/29/1995 | CA1336821C Therapeutic nucleosides |
08/29/1995 | CA1336820C Fluorinated nucleosides and process for treating retrovirus infections therewith |
08/29/1995 | CA1336819C Orally administrable ibuprofen compositions |